Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel.

Berliere M, Dalenc F, Malingret N, Vindevogel A, Piette P, Roche H, Donnez J, Symann M, Kerger J, Machiels JP.

BMC Cancer. 2008 Feb 21;8:56. doi: 10.1186/1471-2407-8-56.

2.

Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial.

Roché H, Fumoleau P, Spielmann M, Canon JL, Delozier T, Serin D, Symann M, Kerbrat P, Soulié P, Eichler F, Viens P, Monnier A, Vindevoghel A, Campone M, Goudier MJ, Bonneterre J, Ferrero JM, Martin AL, Genève J, Asselain B.

J Clin Oncol. 2006 Dec 20;24(36):5664-71. Epub 2006 Nov 20.

PMID:
17116941
3.

Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies.

André M, Baudoux E, Bron D, Canon JL, D'Hondt V, Fassotte MF, D'Hondt L, Fillet G, Humblet Y, Jerusalem G, Vermeulen P, Symann M, Beguin Y.

Transfusion. 2003 Jan;43(1):50-7.

PMID:
12519430
4.

Chemoprotection and selection by chemotherapy of multidrug resistance-associated protein-1 (MRP1) transduced cells.

D'Hondt V, Symann M, Machiels JP.

Curr Gene Ther. 2001 Nov;1(4):359-66. Review.

PMID:
12109062
5.

Immunological recovery and tumour-specific immunotherapeutic approaches to post-autologous haematopoietic stem cell transplantation.

Guillaume T, Rubinstein DB, Symann M.

Baillieres Best Pract Res Clin Haematol. 1999 Mar-Jun;12(1-2):293-306. Review.

PMID:
11001000
6.

Autologous peripheral blood stem cell transplantation for lung cancer.

Guillaume T, Rubinstein DB, Zaner KS, Humblet Y, Symann M.

Baillieres Best Pract Res Clin Haematol. 1999 Mar-Jun;12(1-2):233-46. Review.

PMID:
11000996
7.

Pitfalls in the detection of disseminated non-hematological tumor cells.

Goeminne JC, Guillaume T, Symann M.

Ann Oncol. 2000 Jul;11(7):785-92. Review.

PMID:
10997804
8.

Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients.

Vandercam B, Gérain J, Humblet Y, Ferrant A, Wauters G, Moreau M, Longueville J, Symann M, Straetmans N.

Ann Hematol. 2000 Mar;79(3):152-7.

PMID:
10803938
9.

Human megakaryocyte polyploidization is associated with a decrease in GPIIIA expression.

Baatout S, Chatelain B, Staquet P, Symann M, Chatelain C.

Anticancer Res. 1999 Nov-Dec;19(6B):5187-9.

PMID:
10697532
10.

Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients.

Richel DJ, Johnsen HE, Canon J, Guillaume T, Schaafsma MR, Schenkeveld C, Hansen SW, McNiece I, Gringeri AJ, Briddell R, Ewen C, Davies R, Freeman J, Miltenyi S, Symann M.

Bone Marrow Transplant. 2000 Feb;25(3):243-9.

11.

The G and F contents in megakaryocyte cell lines after stimulation with phorbol myristate acetate.

Baatout S, Chatelain B, Staquet P, Symann M, Chatelain C.

Anticancer Res. 1999 Jul-Aug;19(4B):3259-64.

PMID:
10652621
12.

Protein content and number of nucleolar organizer regions are enhanced during phorbol ester-induced differentiation of cultured human megakaryocytic cells.

Baatout S, Chatelain B, Staquet P, Symann M, Chatelain C.

Anticancer Res. 1999 Jul-Aug;19(4B):3229-35.

PMID:
10652616
13.

Interaction between protein kinase C and actin in megakaryocyte polyploidization.

Baatout S, Chatelain B, Staquet P, Symann M, Chatelain C.

Anticancer Res. 1999 Sep-Oct;19(5B):4193-8.

PMID:
10628374
15.

ESTIC position paper: high-dose chemotherapy for breast cancer, investigation should continue.

Crown J, Coiffier B, Cortés-Funes H, Guillaume T, Kanz L, Kvalheim G, Marty M, Symann M.

Ann Oncol. 1999 Aug;10(8):903-5. Review. No abstract available.

PMID:
10509150
16.

Retroviral-mediated transfer of genes encoding interleukin-2 and interleukin-12 into fibroblasts increases host antitumor responsiveness.

Govaerts AS, Guillaume T, André M, Bayat B, Feyens AM, Hawley TS, Fong AZ, Hawley RG, Symann M.

Cancer Gene Ther. 1999 Sep-Oct;6(5):447-55.

17.

Clearance kinetics of CD34+ cells from peripheral blood: an independent predictor of hematologic recovery after high-dose chemotherapy and hematopoietic stem cell transplantation.

D'Hondt L, Wuu J, André M, Lerberghe C, Guillaume T, Feyens AM, Humblet Y, Dromelet A, Chatelain B, Longueville J, Stewart F, D'Hondt V, Symann M.

Bone Marrow Transplant. 1999 Sep;24(5):483-9.

18.

International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury.

Shipp MA, Abeloff MD, Antman KH, Carroll G, Hagenbeek A, Loeffler M, Montserrat E, Radford JA, Salles G, Schmitz N, Symann M, Armitage JO, Philip T, Coiffier B.

J Clin Oncol. 1999 Jan;17(1):423-9. Review. No abstract available.

PMID:
10458261
19.
20.

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU).

Van Cutsem E, Cunningham D, Ten Bokkel Huinink WW, Punt CJ, Alexopoulos CG, Dirix L, Symann M, Blijham GH, Cholet P, Fillet G, Van Groeningen C, Vannetzel JM, Levi F, Panagos G, Unger C, Wils J, Cote C, Blanc C, Hérait P, Bleiberg H.

Eur J Cancer. 1999 Jan;35(1):54-9.

PMID:
10211088
21.

Retrovirus-mediated gene transfer of the human multidrug resistance-associated protein into hematopoietic cells protects mice from chemotherapy-induced leukopenia.

Machiels JP, Govaerts AS, Guillaume T, Bayat B, Feyens AM, Lenoir E, Goeminne JC, Cole S, Deeley R, Caruso M, Bank A, Symann M, D'Hondt V.

Hum Gene Ther. 1999 Mar 20;10(5):801-11.

PMID:
10210147
22.

International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury.

Shipp MA, Abeloff MD, Antman KH, Carroll G, Hagenbeek A, Loeffler M, Montserrat E, Radford JA, Salles G, Schmitz N, Symann M, Armitage JO, Coiffier B, Philip T.

Ann Oncol. 1999 Jan;10(1):13-9. Review. No abstract available.

PMID:
10076716
23.

Analysis of megakaryocytes by flow cytometry.

Baatout S, Chatelain B, Staquet P, Symann M, Chatelain C.

Haematologia (Budap). 1998;29(3):213-28.

PMID:
10069447
24.

Endomitotic index of megakaryocytes measured by flow cytometry helps to diagnose hematological disorders with abnormal platelet counts.

Baatout S, Chatelain B, Staquet P, Symann M, Chatelain C.

Anticancer Res. 1998 Sep-Oct;18(5A):3347-53.

PMID:
9858907
25.

Induction and enhancement of normal human megakaryocyte polyploidization are concomitant with perturbation in the actin metabolism.

Baatout S, Chatelain B, Staquet P, Symann M, Chatelain C.

Eur J Clin Invest. 1998 Oct;28(10):845-55.

PMID:
9792999
26.

Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation.

Guillaume T, Rubinstein DB, Symann M.

Blood. 1998 Sep 1;92(5):1471-90. Review. No abstract available.

27.

Inhibition of tubulin polymerization in megakaryocyte cell lines leads to polyploidization which affects the metabolism of actin.

Baatout S, Chatelain B, Staquet P, Symann M, Chatelain C.

Anticancer Res. 1998 May-Jun;18(3A):1553-61.

PMID:
9673370
28.
29.
30.

Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome.

Tilly H, Gaulard P, Lepage E, Dumontet C, Diebold J, Plantier I, Berger F, Symann M, Petrella T, Lederlin P, Brière J.

Blood. 1997 Nov 1;90(9):3727-34.

31.

[Efficiency of high-dose FEC chemotherapy for the mobilization of hematopoietic stem cells into peripheral blood].

D'Hondt L, André M, Canon JL, Guillaume T, Doyen C, Feyens AM, Chatelain B, Dromelet A, Humblet Y, Longueville J, Symann M.

Bull Cancer. 1997 Jul;84(7):729-33. French.

32.

Quantification of CD34+ cells mobilized into the peripheral blood predicts the yield of the leukapheresis product and can replace progenitor assays.

D'Hondt L, André M, Guillaume T, Feyens AM, Humblet Y, Doyen C, Bosly A, Dromelet A, Chatelain B, Symann M.

Cytokines Cell Mol Ther. 1997 Mar;3(1):21-6.

PMID:
9287240
33.

Digital necrosis associated with chronic myeloid leukemia: a rare paraneoplastic phenomenon ... and not a toxicity of recombinant interferon.

D'Hondt L, Guillaume T, Humblet Y, Symann M.

Acta Clin Belg. 1997;52(1):49. No abstract available.

PMID:
9085619
34.

Severe anal condylomata acuminata following high-dose chemotherapy and autologous hematopoietic stem cell transplantation: a case report.

D'Hondt L, Filleul B, Guillaume T, Humblet Y, Longueville J, Willocx R, Symann M.

Acta Gastroenterol Belg. 1996 Oct-Dec;59(4):254-5.

PMID:
9085629
35.

Peripheral blood mononuclear cells from autologous hematopoietic stem cell transplantation recipients produce and respond to IL-12.

Guillaume T, Kubin M, Sekhavat M, Rubinstein DB, Trinchieri G, Symann M.

Bone Marrow Transplant. 1996 Oct;18(4):733-9.

PMID:
8899188
36.

High-dose chemo-radiotherapy cycles for LD small cell lung cancer patients using G-CSF and blood stem cells.

Humblet Y, Bosquée L, Weynants P, Symann M.

Bone Marrow Transplant. 1996 Sep;18 Suppl 1:S36-9. No abstract available.

PMID:
8899169
37.

Digital necrosis associated with chronic myeloid leukemia: a rare paraneoplastic phenomenon.

D'Hondt L, Guillaume T, Humblet Y, Moriau M, Lachapelle JM, Symann M.

Acta Clin Belg. 1995;50(5):297-300.

PMID:
8533531
39.

Tolerance of sequential or simultaneous administration of IL-3 and G-CSF in improving peripheral blood stem cells harvesting following multi-agent chemotherapy: a pilot study.

D'Hondt V, Guillaume T, Humblet Y, Doyen C, Chatelain B, Feyens AM, Staquet P, Osselaer JC, Müll B, Symann M.

Bone Marrow Transplant. 1994 Mar;13(3):261-4.

PMID:
7515299
40.

Consensus conference on intensive chemotherapy plus hematopoietic stem cell transplantation in malignancies, Lyon, June 4-6, 1993.

Coiffier B, Philip T, Burnett AK, Symann ML.

Ann Oncol. 1994 Jan;5(1):19-23. Review. No abstract available.

PMID:
7909684
41.

Consensus Conference on Intensive Chemotherapy Plus Hematopoietic Stem-Cell Transplantation in Malignancies: Lyon, France, June 4-6, 1993.

Coiffier B, Philip T, Burnett AK, Symann ML.

J Clin Oncol. 1994 Jan;12(1):226-31. Review. No abstract available.

PMID:
7903691
43.

IL-3 and peripheral blood stem cell harvesting.

Guillaume T, D'Hondt V, Symann M.

Stem Cells. 1993 May;11(3):173-81. Review.

PMID:
8100463
44.
46.

Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors.

Bosly A, Guillaume T, Brice P, Humblet Y, Staquet P, Doyen C, Chatelain B, Franks CR, Gisselbrecht C, Symann M.

Exp Hematol. 1992 Sep;20(8):962-8.

PMID:
1354620
47.

Proliferative and differentiative potential of murine yolk sac and fetal stem cells.

D'Hondt V, Chatelain C, Symann M.

Bone Marrow Transplant. 1992;9 Suppl 1:16-8. No abstract available.

PMID:
1354522
48.
49.

Recombinant interleukin-2 in metastatic renal cell carcinoma--a European multicentre phase II study.

von der Maase H, Geertsen P, Thatcher N, Jasmin C, Mercatello A, Fosså SD, Symann M, Stoter G, Nagel G, Israel L, et al.

Eur J Cancer. 1991;27(12):1583-9.

PMID:
1782066
50.

Supplemental Content

Loading ...
Support Center